Navigation Links
In the battle to relieve back aches, Cornell researchers create bioengineered spinal disc implants
Date:8/1/2011

ITHACA, N.Y. Every year, millions of people contend with lower back and neck discomfort. With intent to ease their pain, Cornell University engineers in Ithaca and doctors at the Weill Cornell Medical College in New York City have created a biologically based spinal implant that could someday spell relief for these countless sufferers.

Lawrence Bonassar, Ph.D., associate professor of biomedical engineering and mechanical engineering, and Roger Hrtl, M.D., associate professor of neurosurgery at Weill Cornell Medical College and chief of spinal surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, have created bioengineered spinal discs that have been successfully implanted and tested in animals.

The other scientists on the paper are Robby Bowles, Cornell Ph.D. '11, and Harry Gebhard, M.D., of Weill Cornell Medical College.

Their research will be published online Aug. 1, 2011 in the Proceedings of the National Academy of Sciences.

"We've engineered discs that have the same structural components and behave just like real discs," says Bonassar. "The hope is that this promising research will lead to engineered discs that we can implant into patients with damaged discs."

Each year, 40 percent to 60 percent of American adults suffer from chronic back or neck pain. For patients diagnosed with severe degenerative disc disease, or herniated discs, neurosurgeons perform surgery called discectomy removing the spinal disc followed by a fusion of the vertebrate bones to stabilize the spine. In spite of the surgery, the patient's back will likely not feel the same as before their injury.

"The surgery prevents pain, but often limits mobility, which may hinder someone who has an active lifestyle or even end the career of a professional athlete," says Hrtl, who is also the team neurosurgeon for the New York Giants.

Human discs look something like a tire, with the outer part, called the annulus, made of a stiff material, and the inner circle, the nucleus, made of a gel-like substance that gets pressurized and bears weight.

Bonassar's lab, which focuses on the regeneration and analysis of musculoskeletal tissue, engineered artificial discs out of two polymers collagen, which wraps around the outside, and a hydrogel called alginate in the middle. They seeded the implants with cells that repopulate the structures with new tissue. Remarkably, as opposed to artificial implants today that degrade over time, the scientists are seeing that the implants get better as they mature in the body, due to the growth of the cells.

"Our implants have maintained 70 to 80 percent of initial disc height. In fact, the mechanical properties get better with time," says Bonassar.

The implants would treat a broad category of illness called degenerative disc disease a leading cause of disability worldwide. According to Hrtl, an increasing number of patients need treatment or surgery from the degeneration of the intervertebral disc. A surgical procedure approved by the FDA in 2005 involves removing the disc completely and replacing it with an implant made of a combination of metal and plastic, with the aim of mimicking the normal movement of the lumbar and spine.

"Bone or metal or plastic implants are complicated structures which come with a mechanical risk of the structures moving around, or debris from the metal or plastic particles accumulating in the body from wear and tear," says Hrtl.

From a biological perspective, the new discs could create a "huge advantage" over traditional implants because of how they integrate and mature with the vertebrae. This major surgery would become less invasive, safer and come with fewer long-term side effects, he says.

The scientists began collaborating on the project in 2006, first funded by an Ithaca-Weill seed grant. Since then, the project has moved into animal testing stages, and it has received several awards and accolades, including a $325,000 grant from Switzerland's AO Spine foundation and $100,000 in support from NFL Charities.


'/>"/>

Contact: Syl Kacapyr
vpk6@cornell.edu
607-255-7701
Cornell University
Source:Eurekalert

Related biology technology :

1. BD and FIND Achieve Milestone in Global Battle Against MDR-TB
2. Battle of the sexes, fruit-fly style
3. Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance
4. New approaches, technological advances offer promise for obesity treatment
5. Polycystic Kidney Disease Assay at Cornell University Uses Transgenomics Surveyor Nuclease & WAVE Technology
6. Gamida Cell Announces Feasibility Study With Weill Cornell Medical College
7. Under new leadership, Kavli Institute at Cornell evolves from a think tank to a proving ground
8. Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
9. Pixel perfect: Cornell develops a lens-free, pinhead-size camera
10. Understanding the science of solar-based energy: more researchers are better than one
11. Researchers decode viral process that prepares cells for HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:6/1/2016)... , June 1, 2016 ... in Election Administration and Criminal Identification to Boost Global ... a recently released TechSci Research report, " Global Biometrics ... Region, Competition Forecast and Opportunities, 2011 - 2021", the ... billion by 2021, on account of growing security concerns ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
Breaking Biology News(10 mins):